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We propose a statistical modeling technique, called the Hierarchi-
cal Association Rule Model (HARM), that predicts a patient’s pos-
sible future medical conditions given the patient’s current and past
history of reported conditions. The core of our technique is a Bayesian
hierarchical model for selecting predictive association rules (such as
“condition 1 and condition 2 → condition 3”) from a large set of
candidate rules. Because this method “borrows strength” using the
conditions of many similar patients, it is able to provide predictions
specialized to any given patient, even when little information about
the patient’s history of conditions is available.
1. Introduction. The emergence of large-scale medical record databases
presents exciting opportunities for data-based personalized medicine. Pre-
diction lies at the heart of personalized medicine and in this paper we
propose a statistical model for predicting patient-level sequences of med-
ical conditions. We draw on new approaches for predicting the next event
within a “current sequence,” given a “sequence database” of past event
sequences [Rudin et al. (2011a, 2011b)]. Specifically, we propose the Hierar-
chical Association Rule Model (HARM) that generates a set of association
rules such as dyspepsia and epigastric pain → heartburn, indicating that
dyspepsia and epigastric pain are commonly followed by heartburn. HARM
produces a ranked list of these association rules. Patients and caregivers can
use the rules to guide medical decisions [see Hood and Friend (2011), e.g.],
while systems can use predictions to allocate resources [Vogenberg (2009)].
Built-in explanations represent a particular advantage of the association
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rule framework—the rule predicts heartburn because the patient has had
dyspepsia and epigastric pain.
In our setup, we assume that each patient visits a healthcare provider
periodically. At each encounter, the provider records time-stamped medical
conditions experienced since the previous encounter. In this context, we
address several prediction problems such as the following:
• Given data from a sequence of past encounters, predict the next condition
that a patient will report.
• Given basic demographic information, predict the first condition that a pa-
tient will report.
• Given partial data from an encounter (and possibly prior encounters),
predict the next condition.
Though medical databases often contain records from thousands or even
millions of patients, most patients experience only a handful of the massive
set of potential conditions. This patient-level sparsity presents a challenge
for predictive modeling. Our hierarchical modeling approach attempts to
address this challenge by borrowing strength across patients.
The sequential event prediction problem is new, a supervised learning
problem that has been formalized here and by Rudin et al. (2011a, 2011b).
Rules are particularly useful in our context: rules yield very interpretable
models, and their conditional probabilities involve few variables and are thus
more reliable to estimate.
The experiments this paper presents indicate that HARM outperforms
several baseline approaches, including a standard “maximum confidence,
minimum support threshold” technique used in association rule mining, and
also a nonhierarchical version of our Bayesian method [from Rudin et al.
(2011a, 2011b)] that ranks rules using “adjusted confidence.”
More generally, HARM yields a prediction algorithm for sequential data
that can potentially be used for a wide variety of applications beyond con-
dition prediction. For instance, the algorithm can be directly used as a rec-
ommender system (e.g., for vendors such as Netflix, amazon.com or online
grocery stores such as Fresh Direct and Peapod). It can be used to predict
the next move in a video game in order to design a more interesting game,
or it can be used to predict the winners at each round of a tournament (e.g.,
the winners of games in a football season). All of these applications possess
the same basic structure as the condition prediction problem: a database
consisting of sequences of events, where each event is associated to an in-
dividual entity (medical patient, customer, football team). As future events
unfold in a new sequence, our goal is to predict the next event.
In Section 2 we provide basic definitions and present our model. In Sec-
tion 3 we evaluate the predictive performance of HARM, along with several
baselines through experiments on clinical trial data. Section 4 provides re-
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lated work, and Section 5 provides a discussion and offers potential exten-
sions.
2. Method. This work presents a new approach to association rule min-
ing by determining the “interestingness” of rules using a particular (hierar-
chical) Bayesian estimate of the probability of exhibiting condition b, given
a set of current conditions, a. We will first discuss association rule mining
and its connection to Bayesian shrinkage estimators. Then we will present
our hierarchical method for providing personalized condition predictions.
2.1. Definitions. An association rule in our context is an implication
a→ b where the left side is a subset of conditions that the patient has expe-
rienced, and b is a single condition that the patient has not yet experienced
since the last encounter. Ultimately, we would like to rank rules in terms of
“interestingness” or relevance for a particular patient at a given time. Using
this ranking, we make predictions of subsequent conditions. Two common
determining factors of the “interestingness” of a rule are the “confidence”
and “support” of the rule [Agrawal, Imielin´ski and Swami (1993); Piatetsky-
Shapiro (1991)].
The confidence of a rule a→ b for a patient is the empirical probability:
Conf(a→ b) :=
Number of times conditions a and b were experienced
Number of times conditions a were experienced
:= Pˆ (b|a).
The support of set a is as follows:
Support(a) := Number of times conditions a were experienced
∝ Pˆ (a),
where Pˆ (a) is the empirical proportion of times that conditions a were expe-
rienced. When a patient has experienced a particular set of conditions only
a few times, a new single observation can dramatically alter the confidence
Pˆ (b|a) for many rules. This problem occurs commonly in our clinical trial
data, where most patients have reported fewer than 10 total conditions. The
vast majority of rule mining algorithms address this issue with a minimum
support threshold to exclude rare rules, and the remaining rules are evalu-
ated for interestingness [reviews of interestingness measures include those of
Tan, Kumar and Srivastava (2002); Geng and Hamilton (2007)]. The defini-
tion of interestingness is often heuristic, and is not necessarily a meaningful
estimate of P (b|a).
It is well known that problems arise from using a minimum support
threshold. For instance, consider the collection of rules meeting the min-
imum support threshold condition. Within this collection, the confidence
alone should not be used to rank rules: among rules with similar confi-
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dence, the rules with larger support should be preferred. More importantly,
“nuggets,” which are rules with low support but very high confidence, are
often excluded by the threshold. This is problematic, for instance, when
a condition that occurs rarely is strongly linked with another rare condi-
tion; it is essential not to exclude the rules characterizing these conditions.
In our data, the distribution of conditions has a long tail, where the vast
majority of events happen rarely: out of 1800 possible conditions, 1400 occur
less than 10 times. These 1400 conditions are precisely the ones in danger
of being excluded by a minimum support threshold.
Our work avoids problems with the minimum support threshold by rank-
ing rules with a shrinkage estimator of P (b|a). These estimators directly
incorporate the support of the rule. One example of such an estimator is the
“adjusted confidence” [Rudin et al. (2011a, 2011b)]:
AdjConf(a→ b,K) :=
Number of times conditions a and b were experienced
Number of times conditions a were experienced +K
.
The effect of the penalty term K is to pull low-support rules toward the
bottom of the list; any rule achieving a high adjusted confidence must over-
come this pull through either a high enough support or a high confidence.
Using the adjusted confidence avoids the problems discussed earlier: “in-
terestingness” is closely related to the conditional probability P (b|a), and,
among rules with equal confidence, the higher support rules are preferred,
and there is no strict minimum support threshold.
In this work we extend the adjusted confidence model in an important re-
spect, in that our method shares information across similar patients to better
estimate the conditional probabilities. The adjusted confidence is a particu-
lar Bayesian estimate of the confidence. Assuming a Beta prior distribution
for the confidence, the posterior mean is
P˜ (b|a) :=
α+#(a&b)
α+ β +#a
,
where #x is the support of condition x, and α and β denote the parameters
of the (conjugate) Beta prior distribution. Our model allows the parameters
of the Binomial to be chosen differently for each patient and also for each
rule. This means that our model can determine, for instance, whether a par-
ticular patient is more likely to repeat a condition that has occurred only
once, and also whether a particular condition is more likely to repeat than
another.
We note that our approach makes no explicit attempt to infer causal re-
lationships between conditions. The observed associations may in fact arise
from common prior causes such as other conditions or drugs. Thus, a rule
such as dyspepsia → heartburn does not necessarily imply that successful
treatment of dyspepsia will change the probability of heartburn. Rather, the
goal is to accurately predict heartburn in order to facilitate effective med-
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ical management. The article of Shmueli (2010) contains a more complete
discussion of this distinction.
2.2. Hierarchical association rule model (HARM). For a patient i and
a given rule, r, say, we observe yir co-occurrences (number of times lhs and
rhs were experienced), where there were a total of nir encounters that include
the lhs (nir is the support for lhs). We model the number of co-occurrences
as Binomial(nir, pir) and then model pir hierarchically to share information
across groups of similar individuals. Define M as a I ×D matrix of static
observable characteristics for a total of I individuals and D observable char-
acteristics, where we assume D > 1 (otherwise we revert back to a model
with a rule-wise adjustment). Each row of M corresponds to a patient and
each column to a particular characteristic. We define the columns of M to
be indicators of particular patient categories (gender, or age between 30 and
40, e.g.), though they could be continuous in other applications. Let Mi
denote the ith row of the matrix M. We model the probability for the ith
individual and the rth rule pir as coming from a Beta distribution with
parameters piir and τi. We then define piir through the regression model
piir = exp(M
′
iβr + γi), where βr defines a vector of regression coefficients
for rule r and γi is an individual-specific random effect. More formally, we
propose the following model:
yir ∼ Binomial(nir, pir),
pir ∼ Beta(piir, τi),
piir = exp(M
′
iβr + γi).
Under this model,
E(pir|yir, nir) =
yir + piir
nir + piir + τi
,
which is a more flexible form of adjusted confidence. This expectation also
produces nonzero probabilities for a rule even if nir is zero (patient i has
never reported the conditions on the left-hand side of r before). This could
allow rules to be ranked more highly even if nir is zero. The fixed effect
regression component,M′iβr, adjusts piir based on the patient characteristics
in the M matrix. For example, if the entries of M represented only gender,
then the regression model with intercept βr,0 would be βr,0+βr,11male, where
1male is one for male respondents and zero for females. Being male, therefore,
has a multiplicative effect of eβr,1 on piir. In this example, the M
′
iβr value
is the same for all males, encouraging similar individuals to have similar
values of piir. For each rule r, we will use a common prior on all coefficients
in βr; this imposes a hierarchical structure, and has the effect of regularizing
coefficients associated with rare characteristics.
The piir’s allow rare but important “nuggets” to be recommended. Even
across multiple patient encounters, many conditions occur very infrequently.
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In some cases these conditions may still be highly associated with certain
other conditions. For instance, compared to some conditions, migraines are
relatively rare. Patients who have migraines, however, typically also experi-
ence nausea. A minimum support threshold algorithm might easily exclude
the rule “migraines → nausea” if a patient hasn’t experienced many mi-
graines in the past. This is especially likely for patients who have few en-
counters. In our model, the piir term balances the regularization imposed
by τi to, for certain individuals, increase the ranking of rules with high con-
fidence but low support. The τi term reduces the probability associated with
rules that have appeared few times in the data (low support), with the same
effect as the penalty term (K) in the adjusted confidence. Unlike the cross-
validation or heuristic strategies suggested in Rudin et al. (2011a, 2011b),
we estimate τi as part of an underlying statistical model. Within a given
rule, we assume τi for every individual comes from the same distribution.
This imposes additional structure across individuals, increasing stability for
individuals with few observations.
It remains now to describe the precise prior structure on the regression
parameters and hyperparameters. We assign Gaussian priors with mean 0
and variance σ2τ to the τ on the log scale. Since any given patient is unlikely
to experience a specific medical condition, the majority of probabilities are
close to zero. Giving τi a prior with mean zero improves stability by discour-
aging excessive penalties. We assign all elements βr,d of vectors βr a com-
mon Gaussian prior on the log scale with mean µβ and variance σ
2
β. We also
assume each γi comes from a Gaussian distribution on the log scale with
common mean µγ and variance σ
2
γ . Each individual has their own γi term,
which permits flexibility among individuals; however, all of the γi terms
come from the same distribution, which induces dependence between indi-
viduals. We assume diffuse uniform priors on the hyperparameters σ2τ , µβ
and σ2β. Denote Y as the matrix of yir values, N as the matrix of nir val-
ues, and β as the collection of β1, . . . ,βR. The prior assumptions yield the
following posterior:
p,pi, τ,β|Y,N,M∝
I∏
i=1
R∏
r=1
p
yir+piir
ir (1− pir)
nir−yir+τi
×
R∏
r=1
D∏
d=1
Normal(log(βr,d)|µβ, σ
2
β)
×
I∏
i=1
Normal(log(γi)|µγ , σ
2
γ)Normal(log(τi)|0, σ
2
τ ).
HARM produces draws from the (approximate) posterior distribution for
each pir. Since these terms will be used for ranking the rules, we refer to
them as rescaled risk. We also note that, even though the pir’s represent
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Fig. 1. Approximate posterior of rescaled risk for two rules. These are histograms of the
posterior means for the set of patients.
probabilities in our model, they are not interpretable as the probability that
a patient will have a given condition at the next visit to a provider (since our
model is not calibrated to time between visits). Figure 1 shows estimates
of the posterior rescaled risk for high cholesterol → myocardial infarction
and hypertension → myocardial infarction. Comparing the distributions of
related rules can often provide insights into associations in the data, as we
demonstrate in Section 3.2.In the context of medical condition prediction,
these rescaled risks are of interest and we analyze our estimates of their
full posterior distributions in Section 3.2. To rank association rules for the
purpose of prediction, however, we need a single estimate for each probability
(rather than a full distribution), which we chose as the posterior mean. In
practice, we suggest evaluating the mean as well other estimators for each
rescaled risk (the mode or median, e.g.) and selecting the one with the best
performance in each particular application. We carry out our computations
using a Gibbs sampling algorithm, provided in Figure 2.
2.3. Approximate updating. Given a batch of data, HARM makes pre-
dictions based on the posterior distributions of the pir’s. Since the posteriors
are not available in closed form, we need to iterate the algorithm in Figure 2
to convergence in order to make predictions. Each time the patient visits
the physician, each pir could be updated by again iterating the algorithm in
Figure 2 to convergence. In some applications, new data continue to arrive
frequently, making it impractical to compute approximate posterior distri-
butions using the algorithm in Figure 2 for each new encounter. In this
section we provide an approximate updating scheme to incorporate new pa-
tient data after an initial batch of encounters has already been processed.
The approximate scheme can be used for real-time online updating.
Beginning with an initial batch of data, we run the algorithm in Fig-
ure 2 to convergence in order to obtain τˆi and pˆiir, which are defined to
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For a suitably initialized chain, at step v:
1. Update pir from the conjugate Beta distribution given piir, τi,Y,N,M.
2. Update τi using a Metropolis step with proposal τ
∗
i where
log(τ∗i )∼N(τ
(v−1)
i , (scale of jumping dist)).
3. For each rule, update the vector βr using a Metropolis step with
log(β∗r)∼N(β
(v−1)
r , (scale of jumping dist)).
4. Update γi using a Metropolis step with
log(γ∗i )∼N(γ
(v−1)
i , (scale of jumping dist)).
5. Update piir = exp(M
′
iβr + γi).
6. Update µβ ∼N(µˆβ, σ
2
β) where
µˆβ =
(
1
D+R
) R∑
r=1
D∑
d=1
βr,d.
7. Update σ2β ∼ Inv−χ
2(d− 1, σˆ2β) where
σˆ2β =
(
1
D+R− 1
) R∑
r=1
D∑
d=1
(βr,d − µβ)
2.
8. Update σ2τ ∼ Inv−χ
2(I − 1, σˆ2τ ) where σˆ
2
τ =
1
I−1
∑I
i=1(τi − µτ )
2.
9. Update µγ ∼N(µˆγ , σ
2
γ) where µˆγ =
1
I
∑I
i=1 γi.
10. Update σ2γ ∼ Inv−χ
2(I − 1, σˆ2γ) where σˆ
2
γ =
1
I−1
∑I
i=1(γi − µγ)
2.
Fig. 2. Gibbs sampling algorithm for the hierarchical Bayesian association rule modeling
for sequential event prediction (HARM).
be the posterior means of the estimated distributions for τi and piir. The
approximate updating scheme keeps τi and piir fixed to be τˆi and pˆiir. Given
that up to encounter e− 1 we have observed y
(e−1)
ir and n
(e−1)
ir , we are pre-
sented with new observations that have counts y
(newobs.)
ir and n
(newobs.)
ir so
that y
(e)
ir = y
(e−1)
ir + y
(newobs.)
ir and n
(e)
ir = n
(e−1)
ir + n
(newobs.)
ir . In order to up-
date the probability estimates to reflect our total current data, y
(e)
ir , n
(e)
ir , we
will use the following relationship:
P (pir|y
(e)
ir , n
(e)
ir , τˆi, pˆiir)∝ P (y
(newobs.)
ir |n
(newobs.)
ir , pir)
×P (pir|y
(e−1)
ir , n
(e−1)
ir , τˆi, pˆiir).
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The expression P (pir|y
(e−1)
ir , n
(e−1)
ir , τˆi, pˆiir) is the posterior up to encounter
e− 1 and has a Beta distribution. The likelihood of the new observations,
P (y
(newobs.)
ir |n
(newobs.)
ir , pir), is Binomial. Conjugacy implies that the updated
posterior also has a Beta distribution. In order to update the probability
estimates for our hierarchical model, we use the expectation of this distri-
bution, that is,
E(pir|y
(e)
ir , n
(e)
ir , τˆi, pˆiir) =
y
(e−1)
ir + y
newobs.
ir + pˆiir
n
(e−1)
ir + n
newobs.
ir + pˆiir + τˆi
.
3. Application to repeated patient encounters. We present results of
HARM, with the approximate updating scheme in Section 2.3, on co-prescrib-
ing data from a large clinical trial. In the trial, each patient visits a health-
care provider periodically. At each encounter, the provider records time-
stamped medical conditions (represented by MedDRA terms) experienced
since the previous encounter. Thus, each encounter is associated with a se-
quence of medical conditions. These data are from around 42,000 patient
encounters from about 2,300 patients, all at least 40 years old. The matrix of
observable characteristics encodes the basic demographic information: gen-
der, age, and ethnicity. For each patient we have a record of each medication
prescribed and the condition/chief complaint (back pain, asthma, etc.) that
warranted the prescription. We chose to predict patient complaints rather
than prescriptions since there are often multiple prescribing options (medica-
tions) for the same complaint. Some patients had preexisting conditions that
continued throughout the trial. For these patients, we include these preex-
isting conditions in the patient’s list of conditions at each encounter. Other
patients have recurrent conditions for which we would like to predict the
occurrences. If a patient reports the same condition more than once during
the same thirty day period, we only consider the first occurrence of the con-
dition at the first report. If the patient reports the condition once and then
again more than thirty days later, we consider this two separate incidents.
As covariates, we used age, gender, race and drug/placebo (an indicator
of whether the patient was in the treatment or control group for the clinical
trial). We fit age using a series of indicator variables corresponding to four
groups (40–49, 50–59, 60–69, 70+). We included all available covariates in
our simulation studies. In practice, model selection will likely be essential to
select the best subset of covariates for predictive performance. We discuss
covariate selection in further detail in the supplemental article [McCormick,
Rudin and Madigan (2011)].
Our experiments consider only the marginal probabilities (support) and
probabilities conditional on one previous condition. Thus, the left-hand side
of each rule contains either 0 items or 1 item. In our simulations, we used
chains of 5000 iterations, keeping every 10th iteration to compute the mean
we used for ranking and discarding the first thousand iterations.
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In Section 3.1 we present experimental results to compare the predictive
performance of our model to other rule mining algorithms for this type of
problem. In Section 3.2 we use the probability estimates from the model
to demonstrate its ability to find new associations; in particular, we find
associations that are present in the medical literature but that may not be
obvious by considering only the raw data.
3.1. Predictive performance. We selected a sample of patients by assign-
ing each patient a random draw from a Bernoulli distribution with success
probability selected to give a sample of patients on average around 200. For
each patient we drew uniformly an integer ti between 0 and the number of
encounters for that patient. We ordered the encounters chronologically and
used encounters 1 through ti as our training set and the remaining encoun-
ters as the test set. Through this approach, the training set encompasses
the complete set of encounters for some patients (“fully observed”), includes
no encounters for others (“new patients”), and a partial encounter history
of the majority of the test patients (“partially-observed patients”). We be-
lieve this to be a reasonable approximation of the context where this type
of method would be applied, with some patients having already been ob-
served several times and other new patients entering the system for the first
time. We evaluated HARM’s predictive performance using a combination of
common and rare conditions. For each run of the simulation, we use the 25
most popular conditions, then randomly select an additional 25 conditions
for a total of 50.
The algorithm was used to iteratively predict the conditions revealed at
each encounter. For each selected patient, starting with the first test en-
counter, and prior to that encounter’s first condition being revealed, the
algorithm made a prediction of c possible conditions, where c= 3. Note that
to predict the very first condition for a given patient when there are no
previous encounters, the recommendations come from posterior means of
the coefficients estimated from the training set. The algorithm earned one
point if it recommended the current condition before it was revealed, and no
points otherwise. Then, yir and nir were updated to include the revealed con-
dition. This process was repeated for the patient’s remaining conditions in
the first encounter, and repeated for each condition within each subsequent
encounter. We then moved to the next patient and repeated the procedure.
The total score of the algorithm for a given patient was computed as
the total number of points earned for that patient divided by the total
number of conditions experienced by the patient. The total score of the
algorithm is the average of the scores for the individual patients. Thus, the
total score is the average proportion of correct predictions per patient. We
repeated this entire process (beginning with selecting patients) 500 times and
recorded the distribution over the 500 scores. We compared the performance
of HARM (using the same scoring system) against an algorithm that ranks
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Fig. 3. Predictive performance for ( a) all patients, (b) partially-observed patients,
( c) new patients. Each boxplot represents the distribution of scores over 500 runs. For ( a),
each run’s score (an individual point on a boxplot) is based on a sample of approximately
200 patients. For (b) and ( c), each point is based on a subset of these ∼200 patients.
rules by adjusted confidence, for several values of K. We also compared with
the “max confidence minimum support threshold” algorithm for different
values of the support threshold θ, where rules with support below θ are
excluded and the remaining rules are ranked by confidence. For both of
these algorithms, no information across patients is able to be used.
Figure 3 shows the results, as boxplots of the distribution of scores for
the entire collection of partially-observed, fully observed and new patients.
Paired t-tests comparing the mean proportion of correct predictions from
HARM to each of the alternatives had p-values for a significant difference in
our favor less than 10−15. In other words, HARM has statistically superior
performance over all K and θ, that is, better performance than either of
the two algorithms even if their parameters K and θ had been tuned to
the best possible value. For all four values of K for the adjusted confidence,
performance was slightly better than for the plain confidence (K = 0). The
“max confidence minimum support threshold” algorithm (which is a stan-
dard approach to association rule mining problems) performed poorly for
minimum support thresholds of 2 and 3. This poor performance is likely
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(a) (b)
Fig. 4. Propensity of myocardial infarction in patients who have reported high cholesterol
or hypertension using ( a) HARM and (b) (unadjusted) confidence. For each demographic
group, high cholesterol (HC) is on the left and hypertension (Hy) is on the right. Thick
lines represent the middle half of the posterior mean propensities for respondents in the
indicated demographic group. Outer lines represent the middle 90% and dots represent
the mean. The vast majority of patients did not experience a myocardial infarction, which
places the middle 90% of the distributions in plot (b) approximately at zero.
due to the sparse information we have for each patient. Setting a minimum
support threshold as low as even two eliminates many potential candidate
rules from consideration.
The main advantage of our model is that it shares information across
patients in the training set. This means that in early stages where the ob-
served yir and nir are small, it may still be possible to obtain reasonably ac-
curate probability estimates, since when patients are new, our recommenda-
tions depend heavily on the behavior of previously observed similar patients.
This advantage is shown explicitly through Figures 3(b) and 3(c), which per-
tain to partially-observed and new patients, respectively. The advantage of
HARM over the other methods is more pronounced for new patients: in
cases where there are no data for each patient, there is a large advantage
to sharing information. We performed additional simulations which further
illustrate this point and are presented in the supplement [McCormick, Rudin
and Madigan (2011)].
3.2. Association mining. The conditional probability estimates from our
model are also a way of mining a large and highly dependent set of associa-
tions.
Ethnicity, high cholesterol or hypertension → myocardial infarction: Fig-
ure 4(a) shows the distribution of posterior mean propensity for myocar-
dial infarction (heart attack) given two conditions previously reported as
risk factors for myocardial infarction: high cholesterol and hypertension [see
Kukline, Yoon and Keenan (2010) for a recent review]. Each bar in the figure
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corresponds to the set of respondents in a specified ethnic group. For Cau-
casians, we typically estimate a higher probability of myocardial infarction
in patients who have previously had high cholesterol. In African Ameri-
cans/Hispanics and Asian patients, however, we estimate a generally higher
probability for patients who have reported hypertension. This distinction
demonstrates the flexibility of our method in combining information across
respondents who are observably similar. Race-ethnic differences in risk fac-
tors for coronary heart disease have attracted considerable attention in the
medical literature [see, e.g., Rosamond et al. (2007) or Willey et al. (2011)].
As a comparison, we also included the same plot using (unadjusted) con-
fidence, in Figure 4(b). In both Figure 4(a) and Figure 4(b), the black dots
are the mean across all the patients, which are not uniformly at zero be-
cause there were some cases of myocardial infarction and hypertension or
high cholesterol. In Figure 4(b), the colored, smaller dots represent the rest
of the middle 90% of the distribution, which appears to be at zero in plot (b)
since the vast majority of patients did not have a myocardial infarction at
all, so even fewer had a myocardial infarction after reporting hypertension
or high cholesterol.
Age, high cholesterol or hypertension, treatment or placebo → myocar-
dial infarction: Since our data come from a clinical trial, we also included
an indicator of treatment vs. placebo condition in the hierarchical regression
component of HARM. Figures 5 and 6 display the posterior means of propen-
sity of myocardial infarction for respondents separated by age and treatment
condition. Figure 5 considers patients who have reported hypertension, Fig-
ure 6 considers patients who have reported high cholesterol. In both Figure
5 and Figure 6, it appears that the propensity of myocardial infarction pre-
dicted by HARM is greatest for individuals between 50 and 70, with the
association again being stronger for high cholesterol than hypertension.
For both individuals with either high cholesterol or hypertension, use
of the treatment medication was associated with increased propensity of
myocardial infarction. This effect is present across nearly every age category.
The distinction is perhaps most clear among patients in their fifties in both
Figure 5 and Figure 6. The treatment product in this trial has been linked
to increased risk of myocardial infarction in numerous other studies. The
product was eventually withdrawn from the market by the manufacturer
because of its association with myocardial infarctions.
The structure imposed by our hierarchical model gives positive probabil-
ities even when no data are present in a given category; in several of the
categories, we observed no instances of a myocardial infarction, so estimates
using only the data cannot differentiate between the categories in terms of
risk for myocardial infarction, as particularly illustrated through Figure 6(b).
4. Related works. Four relevant works on Bayesian hierarchical model-
ing and recommender systems are those of DuMouchel and Pregibon (2001),
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(a) (b)
Fig. 5. Propensity of myocardial infarction in patients who have reported hypertension,
estimated by ( a) HARM and (b) (unadjusted) confidence. For each demographic group,
the placebo (P) is on the left and the treatment medication (T) is on the right. Thick
lines represent the middle half of the posterior mean propensities for respondents in the
indicated demographic group. Outer lines represent the middle 90% and dots represent the
mean. Overall the propensity is higher for individuals who take the study medication than
those who do not.
Breese, Heckerman and Kadie (1998), Condliff et al. (1999) and Agarwal,
Zhang and Mazumder (2012). DuMouchel and Pregibon (2001) deal with
the identification of interesting itemsets (rather than identification of rules).
Specifically, they model the ratio of observed itemset frequencies to base-
line frequencies computed under a particular model for independence. Nei-
ther Condliff et al. (1999) nor Breese, Heckerman and Kadie (1998) aim
to model repeat purchases (recurring conditions). Breese, Heckerman and
Kadie (1998) use Bayesian methods to cluster users, and also suggest a Bayes-
ian network. Condliff et al. (1999) present a hierarchical Bayesian approach
to collaborative filtering that “borrows strength” across users. Agarwal,
(a) (b)
Fig. 6. Propensity of myocardial infarction in patients who have reported high cholesterol,
estimated by ( a) HARM and (b) (unadjusted) confidence.
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Zhang and Mazumder (2012) also build a personalized recommender sys-
tem that models item-item similarities. Their model uses logistic regression
for estimating pir rather than using piir and τi. This has the advantage of
being a simpler hierarchical model, but loses the interpretability our model
has through using association rules. It also loses the potential advantage of
estimating only conditional probabilities involving few variables.
As far as we know, the line of work by Davis et al. (2010) is the first to
use an approach from recommender systems to predict medical conditions,
though in a completely different way than ours; it is based on vector sim-
ilarity, in the same way as Breese, Heckerman and Kadie (1998). [Also see
references in Davis et al. (2010) for background on collaborative filtering.]
Also in the context of learning in medical problems, Gopalakrishnan et al.
(2010) used decision rules chosen using a Bayesian network to predict disease
state from biomarker profiling studies.
5. Conclusion and future work. We have presented a hierarchical model
for ranking association rules for sequential event prediction. The sequential
nature of the data is captured through rules that are sensitive to time order,
that is, a→ b indicates conditions a are followed by conditions b. HARM
uses information from observably similar individuals to augment the (often
sparse) data on a particular individual; this is how HARM is able to estimate
probabilities P (b|a) before conditions a have ever been reported. In the
absence of data, hierarchical modeling provides structure. As more data
become available, the influence of the modeling choices fade as greater weight
is placed on the data. The sequential prediction approach is especially well
suited to medical condition prediction, where experiencing two conditions in
succession may have different clinical implications than experiencing either
condition in isolation.
Model selection is important for using our method in practice. There are
two types of model selection required for HARM: the choice of covariates
encoded by the matrix M, and the collection of available rules. For the
choice of covariates in M, standard feature selection methods can be used,
for instance, a forward stagewise procedure where one covariate at a time
is added as performance improves, or a backward stagewise method where
features are iteratively removed. Another possibility is to combine covari-
ates, potentially through a method similar to model-based clustering [Fraley
and Raftery (2002)]. To perform model selection on the choice of rules, it is
possible to construct analogous “rule selection” methods as one might use
for a set of covariates. A forward stagewise procedure could be constructed,
where the set of rules is gradually expanded as prediction performance in-
creases. Further, it is possible to combine a set of rules into a single rule
as in model-based clustering; for example, rather than separate rules where
the left side is either “dorsal pain,” “back pain,” “low back pain,” or “neck
pain,” we could use simply “back or neck pain” for all of them.
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Another direction for future work is to incorporate a model for higher-
order dependence, along the line of work by Berchtold and Raftery (2002).
An algorithm for sequential event prediction is presented in ongoing work
[Letham, Rudin and Madigan (2011)], which is loosely inspired by the ideas
of Berchtold and Raftery (2002), but does not depend on association rules.
A third potential future direction is to design a more sophisticated online
updating procedure than the one in Section 2.3. It may be possible to design
a procedure that approximately updates all of the hyperparameters as more
data arrive.
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SUPPLEMENTARY MATERIAL
Additional simulation results (DOI: 10.1214/11-AOAS522SUPP; .pdf).
In the supplement we present additional simulation results which speak to
the performance of HARM.
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